ClinicalMetric / Countries / Portugal / mantle cell lymphoma mcl
← 🇵🇹 Portugal Trials
🇵🇹 Portugal Country × Condition

mantle cell lymphoma mcl Clinical Trials in Portugal

Active clinical trials for mantle cell lymphoma mcl with research sites in Portugal. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇵🇹 Portugal

Active Trials in Portugal (1)

NCT07285590 Phase 2
Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma

Enrollment
50 pts
Country
🇵🇹 Portugal
Grupo Español de Linfomas y Transpl...
View Trial →

Frequently Asked Questions

How many mantle cell lymphoma mcl clinical trials are active in Portugal?
There are currently 1 active clinical trials for mantle cell lymphoma mcl with sites in Portugal, of which 1 are actively recruiting patients.
How can I join a mantle cell lymphoma mcl clinical trial in Portugal?
To join a mantle cell lymphoma mcl clinical trial in Portugal, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Portugal directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are mantle cell lymphoma mcl trials in Portugal?
Active mantle cell lymphoma mcl trials in Portugal span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Portugal Trials → Global mantle cell lymphoma mcl Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology